Information Journal Paper
APA:
Copy. (2021). Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial. LANCET INFECTIOUS DISEASES, -(-), 0-0. SID. https://sid.ir/paper/681455/en
Vancouver:
Copy. Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial. LANCET INFECTIOUS DISEASES[Internet]. 2021;-(-):0-0. Available from: https://sid.ir/paper/681455/en
IEEE:
Copy, “Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial,” LANCET INFECTIOUS DISEASES, vol. -, no. -, pp. 0–0, 2021, [Online]. Available: https://sid.ir/paper/681455/en